Research Director, PhD
CRCT/INSERM/CNRS/UPS, France
As a Research director, my fields of scientific expertise are malignant hematology, immunology, anti-tumoral pharmacology and immunotherapy. Since 2010, I focused my research on CLL from basic science (Side Population, gene expression/regulation, impact of NLCs) to pre-clinical science (anti-CD20 or anti-CD37 therapy, targeted therapies) to better decipher evolution and resistance of CLL cells in their micro-environment.
